EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Modern Pathology

• Publication date

  2017-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/modpathol.2017.37PMID 28548121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features

  2017cited by this paper
• WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues

  2017cited by this paper
• Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays.

  2017cited by this paper
• The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications

  2016cited by this paper
• Mutational Analysis of Extranodal NK/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer Panel

  2016cited by this paper
• Natural Killer Cell Lymphoma: A Case with Classification Dilemma.

  2016cited by this paper
• Extranodal NK/T cell lymphoma and aggressive NK cell leukaemia: evidence for their origin on CD56+bright CD16−/+dim NK cells

  2015cited by this paper
• Aggressive mature natural killer cell neoplasms: report on a series of 12 European patients with emphasis on flow cytometry based immunophenotype and DNA content of neoplastic natural killer cells

  2015cited by this paper
• Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type

  2015cited by this paper
• The first report of a previously undescribed EBV-negative NK-cell lymphoma of the GI tract presenting as chronic diarrhoea with eosinophilia

  2015cited by this paper
• Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation

  2015cited by this paper
• Six cases of aggressive natural killer-cell leukemia in a Chinese population.

  2014cited by this paper
• JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma

  2014cited by this paper
• DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus.

  2014cited by this paper
• Favorable outcome in a child with EBV-negative aggressive NK cell leukemia

  2013cited by this paper
• EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity.

  2013cited by this paper
• Polycomb group proteins and MYC: the cancer connection

  2013cited by this paper
• Epstein-Barr virus-negative aggressive natural killer-cell leukaemia with high P-glycoprotein activity and phosphorylated extracellular signal-regulated protein kinases 1 and 2

  2012cited by this paper
• Epstein-Barr virus infection as an epigenetic driver of tumorigenesis.

  2012cited by this paper
• Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.

  2012cited by this paper
• Activated oncogenic pathways and therapeutic targets in extranodal nasal‐type NK/T cell lymphoma revealed by gene expression profiling

  2011cited by this paper
• Myc Enforces Overexpression of EZH2 in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms

  2011cited by this paper
• Myc Regulates the Transcription of the PRC2 Gene To Control the Expression of Developmental Genes in Embryonic Stem Cells

  2011cited by this paper
• Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses.

  2011cited by this paper
• Polycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines

  2009cited by this paper
• Aggressive Natural Killer Cell Leukemia: Is Epstein-Barr Virus Negativity an Indicator of a Favorable Prognosis?

  2009cited by this paper
• EZH2 is essential for glioblastoma cancer stem cell maintenance.

  2009cited by this paper
• MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.

  2008cited by this paper
• Aggressive Natural Killer Cell Leukemia: Report of a Chinese Series and Review of the Literature

  2007cited by this paper
• Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells

  2004cited by this paper
• Aggressive Natural Killer-cell Leukemia: Report of Five Cases and Review of the Literature

  2004cited by this paper
• Monomorphic Agranular Natural Killer Cell Lymphoma/Leukemia with No Epstein-Barr Virus Association

  1999cited by this paper
• Molecular and Cellular Pathobiology Myc Acts via the Pten Tumor Suppressor to Elicit Autoregulation and Genome-wide Gene Repression by Activation of the Ezh2 Methyltransferase

  year unknowncited by this paper

• Hemophagocytic lymphohistiocytosis associated with extranodal NK/T cell lymphoma, nasal type or aggressive NK cell leukemia: a retrospective multicenter study of Jiangsu Cooperative Lymphoma Group (JCLG)

  2026cites this paper
• Blood- and bone marrow-based mature T-cell and natural killer cell leukemias and lymphomas: a summary in the series of the 2023 SH/EAHP Workshop.

  2025cites this paper
• Epstein-Barr virus-positive T- and NK-cell lymphoproliferative disorders: Report from the 2023 SH/EA4HP Lymphoma Workshop.

  2025cites this paper
• The fifth edition of the WHO classification of mature T cell, NK cell and stroma-derived neoplasms

  2025cites this paper
• 5TH EDITION OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES.

  2024cites this paper
• From the midfacial destructive drama to the unfolding EBV story: a short history of EBV-positive NK-cell and T-cell lymphoproliferative diseases.

  2024cites this paper
• The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors – an overview and update

  2024cites this paper
• Aggressive Natural Killer Cell Leukemia: A Brief Overview of Its Genomic Landscape, Histological Features, and Current Management

  2022cites this paper
• Aggressive Natural Killer Cell Leukemia in an Adolescent Patient: A Case Report and Literature Review

  2022cites this paper
• EBV associated T‐ and NK‐cell lymphoproliferative diseases: A comprehensive overview of clinical manifestations and novel therapeutic insights

  2022cites this paper
• Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma

  2021cites this paper
• Aggressive natural killer cell leukemia: diagnosis, treatment recommendations, and emerging therapies

  2021influential citation
• Extranodal NK/T-cell lymphoma, nasal type without evidence of EBV infection

  2020influential citation
• Challenges and limitations in the primary diagnosis of T‐cell and natural killer cell/T‐cell lymphoma in bone marrow biopsy

  2020cites this paper
• Genomic and Immunophenotypic Landscape of Aggressive NK-Cell Leukemia

  2020cites this paper
• Comprehensive molecular genetic studies of EBV-negative aggressive NK-cell leukemia/lymphoma.

  2020cites this paper
• Aggressive NK Cell Leukemia: Current State of the Art

  2020influential citation
• Relapsed EBV-negative aggressive NK cell Lymphoma of the orbit and scalp - A Case Report with review of literature

  2020cites this paper
• The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy

  2020cites this paper
• Hepatosplenic T Cell Lymphoma Involved Small Vessels of Central Nervous System

  2020influential citation
• ReviewThe immune checkpoint PD-1 in Natural Killer cells: expression

  2020cites this paper
• Pembrolizumab in newly diagnosed EBV-negative extranodal natural killer/T-cell lymphoma: A case report.

  2019cites this paper
• EBV-Associated Lymphoproliferative Disorders: Update in Classification.

  2019cites this paper
• Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.

  2019cites this paper
• What is new in mature T-cell leukemias?

  2019cites this paper
• Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting

  2019cites this paper
• Clonal sequence tracking reveals TET2-mutated extranodal NK/T-cell lymphoma disseminated independent of Epstein Barr virus

  2019cites this paper
• Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases

  2019cites this paper
• Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases

  2019cites this paper
• Non-EBV-Related Aggressive NK-Cell Leukemia: An Oncohematological Great Imitator

  2018cites this paper
• Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target

  2018cites this paper
• Aggressive natural killer cell leukemia mimicking interstitial lung diseases with the activation of the mitogen-activated protein kinase pathway.

  2018cites this paper
• EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts

  2018cites this paper
• Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update.

  2018cites this paper
• Aggressive natural killer (NK)‐cell leukaemia and extranodal NK/T‐cell lymphoma are two distinct diseases that differ in their clinical presentation and cytogenetic findings

  2018cites this paper
• IL-13 Contributes to Drug Resistance of NK/T-Cell Lymphoma Cells by Regulating ABCC4

  2018cites this paper
• CD56-Negative Aggressive NK Cell Leukemia Relapsing as Multiple Cranial Nerve Palsies: Case Report and Literature Review

  2017cites this paper
• Mutational Analysis of Extranodal NK/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer Panel

  2016cites this paper